Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.

Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into a license and collaboration agreement with Innovent ...

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

New AlphaMedix data showed sustained and clinically meaningful responses across both RLT-naïve and RLT-exposed patients with unresectable or metastatic GEP-NETsFirst phase 2 study to evaluate TAT with ...

A new study suggests that mRNA vaccines for COVID-19 could help boost the effects of immunotherapy drugs for some cancer patients.